They developed a headband to treat migraine: how it works and from when it will be available

migraine 4.jpg


According to the UNCiencia agency, the principle on which Viex Tens is based was discovered by two internationally renowned doctors in the mid-1960s. Ronald Melzack and Patrick Wall proved that by stimulating certain nerve areas it was possible to inhibit pain.

How the headband works to treat migraine

Viex Tens wears a series of electrostimulators located just at the height of the trigeminal nerve terminals, on the person’s forehead, above the eyebrows. And it works by generating faint electrical stimuli on the skin, in order to inject microelectricity into the trigeminal nerve. Finally, get a decrease in pain.

For migraine sufferers, the recommendation is wear the cap for 30 minutes, once or twice a day. And thus prevent the use of medications.

migraine 3.jpg

José Intelesano, Diego Beltramone, Laura Vega, Agustín Bornacin, Hugo Díaz Fajreldines and María Jimena Martínez y Atanes.

José Intelesano, Diego Beltramone, Laura Vega, Agustín Bornacin, Hugo Díaz Fajreldines and María Jimena Martínez y Atanes.


Tests show that a device of this type can reduce the level of pain by up to 75% and, with it, the consumption of drugs. Generates relief especially in people who cannot receive special medicationsuch as pregnant women. In addition, the electrical stimulation is almost imperceptible, like a tickling. Some people do not feel anything and it is really effective”, they warn UNCiencia from the research team.

When will the headband be available to treat migraine

At the moment, they have a prototype. But DINES posted on his official website that “The VIEX-TENS equipment is under development, a transcutaneous neurostimulator for the non-invasive treatment of migraine”. That impulse has to do with an award they received for the InnovACba Programfrom the province of Córdoba, which will allow production to advance.

The next step is the National Food, Drug and Medical Technology Administration approval (ANMAT): “We are in the preliminary stages to be able to commercialize it. We have to obtain certification from ANMAT for its sale at the national level or from the Ministry of Health of Córdoba to market it in the province,” Beltramone told La Voz.

“The idea is not to compete with the pharmacological treatments that already exist. We especially focused on two cases of migraine: patients who got used to drugs and can no longer increase the dose, and pregnant women who can not receive these drugs “he added.

“Normally the health professional works with drugs. I think it will be possible to overcome that cultural barrierbecause the results we have are very good and does not generate side effects like drugs”, he concluded.

Leave a Reply